PCIF1 and neoplasm: Given that RNA modifications can influence drug resistance, metastasis and tumour microenvironment (TME) interactions,18 understanding how PCIF1‐mediated m6Am modifications contribute to OSCC malignancy may provide novel therapeutic targets for intervention.